Search research articles
Contact Us
Filters
Showing results (21-30 of 335) with videos related to
Page
of 34
Sort By:
Annual Review of Immunology
|
January 21, 2014
Immunology of relapse and remission in multiple sclerosis
Lawrence Steinman
Proceedings of the National Academy of Sciences of the United States of America
|
May 20, 2009
The gray aspects of white matter disease in multiple sclerosis
Lawrence Steinman
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 14, 2026
Targeting EBV is a viable therapeutic strategy in MS: YES
Lawrence Steinman
Nature Reviews. Immunology
|
May 16, 2009
A molecular trio in relapse and remission in multiple sclerosis
Lawrence Steinman
Proceedings of the National Academy of Sciences of the United States of America
|
February 2, 2023
An intrinsically disordered protein, osteopontin, driving neuropathology in Alzheimer's dementia
Lawrence Steinman
Immunologic Research
|
April 29, 2014
Development of therapies for autoimmune disease at Stanford: a tale of multiple shots and one goal
Lawrence Steinman
Science (New York, N.Y.)
|
July 13, 2004
Immune therapy for autoimmune diseases
Lawrence Steinman
Science Signaling
|
January 17, 2013
Inflammatory cytokines at the summits of pathological signal cascades in brain diseases
Lawrence Steinman
Nature Medicine
|
February 8, 2013
Weighing in on autoimmune disease: 'Hub-and-spoke' T cell traffic in autoimmunity
Lawrence Steinman
Med (New York, N.Y.)
|
April 2, 2021
Capturing pathogenic immune cells before they home to brain
Lawrence Steinman
Page
of 34
Search research articles
Search
Showing results (21-30 of 335) with videos related to
Sort By:
Page
of 34
Annual Review of Immunology
|
January 21, 2014
Immunology of relapse and remission in multiple sclerosis
Lawrence Steinman
Proceedings of the National Academy of Sciences of the United States of America
|
May 20, 2009
The gray aspects of white matter disease in multiple sclerosis
Lawrence Steinman
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 14, 2026
Targeting EBV is a viable therapeutic strategy in MS: YES
Lawrence Steinman
Nature Reviews. Immunology
|
May 16, 2009
A molecular trio in relapse and remission in multiple sclerosis
Lawrence Steinman
Proceedings of the National Academy of Sciences of the United States of America
|
February 2, 2023
An intrinsically disordered protein, osteopontin, driving neuropathology in Alzheimer's dementia
Lawrence Steinman
Immunologic Research
|
April 29, 2014
Development of therapies for autoimmune disease at Stanford: a tale of multiple shots and one goal
Lawrence Steinman
Science (New York, N.Y.)
|
July 13, 2004
Immune therapy for autoimmune diseases
Lawrence Steinman
Science Signaling
|
January 17, 2013
Inflammatory cytokines at the summits of pathological signal cascades in brain diseases
Lawrence Steinman
Nature Medicine
|
February 8, 2013
Weighing in on autoimmune disease: 'Hub-and-spoke' T cell traffic in autoimmunity
Lawrence Steinman
Med (New York, N.Y.)
|
April 2, 2021
Capturing pathogenic immune cells before they home to brain
Lawrence Steinman
Page
of 34